Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis Veronique MichaudLucy I. DarakjianJacques Turgeon Clinical Pharmacology (L Brunetti, Section Editor) 17 January 2022 Pages: 79 - 98
Role of Inflammatory Cytokines in Pathophysiology of Psoriasis Ravi Kant SharmaManu Rashmi SharmaSunil Kumar Clinical Pharmacology (L Brunetti, Section Editor) 03 January 2022 Pages: 99 - 105
Endophthalmitis: Types and Recent Trends in Diagnosis Surya Prakash SharmaReema BansalSunil Kumar Clinical Pharmacology (L Brunetti, Section Editor) 05 January 2022 Pages: 106 - 111
Anti-Disialoganglioside-2 Monoclonal Antibodies as an Emerging Therapeutic Approach in Treatment of High-Risk Neuroblastoma Hemant KumarRachna Gupta Clinical Pharmacology (L Brunetti, Section Editor) 05 February 2022 Pages: 112 - 120
Emicizumab: an FDA-Approved Monoclonal Antibody in the Treatment of Hemophilia A Doddolla LingamaiahSunitha NSSameer Dhingra Clinical Pharmacology (L Brunetti, Section Editor) 19 January 2022 Pages: 121 - 129
Phytochemicals in Breast Cancer-Induced Osteoclastogenesis and Bone Resorption: Mechanism and Future Perspective Subrata Kumar PoreEun-Ryeong Hahm Cancer Chemoprevention (R Agarwal, C Rao and S Yu, Section Editors) 22 January 2022 Pages: 130 - 148
Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach Rajan RoltaDeeksha SalariaKamal Dev Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor) 08 March 2022 Pages: 149 - 170